Brain Fog, Memory Decline? Understanding Symptoms and Treatments of Alzheimer’s Disease, Parkinson’s Disease, and Dementia

As Hong Kong’s population ages, neurodegenerative conditions are becoming increasingly common. Alzheimer’s disease primarily impacts cognitive function—leading to short-term memory loss, communication challenges, and behavioral changes. In contrast, Parkinson’s disease mainly affects motor control, resulting in resting tremors and restricted movement. Standard management strategies typically include prescribed medications, rehabilitation, and advanced techniques like Deep Brain Stimulation (DBS). Additionally, modern neurological approaches increasingly focus on supportive therapies that help protect neural health and enhance daily functional recovery.

What is the Relationship Between Alzheimer’s Disease, Parkinson’s Disease, and Dementia?

• Dementia (Cognitive Impairment): An umbrella term describing a syndrome of declining brain function that impairs memory, thinking, and daily living abilities.
• Alzheimer’s Disease: The most common cause of dementia (accounting for approximately 65% of cases in Hong Kong), primarily affecting cognition and memory.
• Parkinson’s Disease: A disorder that mainly affects motor movement (causing tremors and stiffness). Some patients may also develop dementia symptoms in the advanced stages of the disease.

Common Symptoms of Alzheimer’s Disease and Parkinson’s Disease

Because Alzheimer’s disease and Parkinson’s disease affect different regions of the brain in their early stages, their initial manifestations differ significantly. Alzheimer’s disease presents primarily with cognitive decline, whereas Parkinson’s disease centers on motor function impairment:

Alzheimer’s Disease Symptoms (Primarily Cognitive Decline)

• Forgetting recent events and repeating questions.
• Losing track of time or getting lost in familiar places.
• Difficulty handling daily tasks (e.g., managing finances, cooking).
• Struggling to speak clearly or understand complex speech.
• Developing suspicion, anxiety, or personality changes.
• Losing basic self-care abilities (e.g., eating, dressing).

Parkinson’s Disease Symptoms (Primarily Motor Function Impairment)

• Resting tremors (uncontrolled shaking in hands or feet, like “pill-rolling”).
• Muscle stiffness and reduced facial expressions (“masked face”).
• Sluggish movement and difficulty initiating walking.
• Poor balance and frequent falls.
• Non-motor symptoms: severe constipation, sleep disruptions, and low mood.
• Risk of memory decline or dementia in advanced stages.

Current Treatments for Alzheimer’s Disease and Parkinson’s Disease

While a complete cure is not yet available, medications and rehabilitation can effectively delay disease progression and improve quality of life:

Alzheimer’s Disease Treatments

• Symptom-Modifying Medications: Prescription therapies that regulate neurotransmitters to help maintain memory and cognitive abilities.
• Targeted Biologic Therapies: Anti-amyloid monoclonal antibody therapies designed to clear abnormal protein accumulations in the brain, suitable for early-stage patients.
• Non-Pharmacological Interventions: Cognitive therapy, regular exercise, and active management of cardiovascular risk factors (blood pressure, blood sugar, and cholesterol).

Parkinson’s Disease Treatments

• Dopamine-Regulating Medications: Pharmacological therapies that restore or mimic essential chemical messengers in the brain to significantly reduce tremors and muscle rigidity.
• Deep Brain Stimulation (DBS): Surgical implantation of micro-electrodes in the brain to modulate abnormal neural signals (suitable for moderate-to-advanced stages).
• Physical and Speech Rehabilitation: Targeted balance training, mobility exercises, and swallowing therapy.

Novel Neurorestorative Adjunctive Therapies

Beyond traditional symptom-management options, stimulating the brain’s “self-repair” capacity is a major focus of modern neurology.

Peptide-based neurorestorative therapies work by mimicking natural neurotrophic factors in the brain to protect nerve cells from damage and encourage neural network reorganization. Clinically, these therapies are often utilized as adjunctive support in stroke recovery, brain injury rehabilitation, and cognitive decline management to help enhance memory and daily functionality.

Learn more: Understanding Brain Repair and Peptide-based neurorestorative therapies

Summary

If a family member shows persistent memory decline or physical tremors, seek medical evaluation promptly. “Early detection and early intervention” are crucial to preserving brain health and quality of life.

References

1. Scheltens, P., et al. (2021). Alzheimer’s disease. The Lancet, 397(10284), 1577–1590.
2. Poewe, W., et al. (2017). Parkinson disease. Nature Reviews Disease Primers, 3(1), 17013.
3. Alvarez, X. A., et al. (2015). Cerebrolysin in mild-to-moderate Alzheimer’s disease: a meta-analysis of randomized controlled clinical trials. Dementia and Geriatric Cognitive Disorders, 38(3-4), 173–186.
4. Livingston, G., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413–446.